VP, Late-Stage & Commercial Biologics DevelopmentAbCellera · Vancouver

VP, Late-Stage & Commercial Biologics Development

🗓️ Posted 2026-09-28 Vancouver Hybrid Science Technology
💰 Salary Not shared 📊 Market 15,000 CAD–25,000 CAD/mo

About the Company

Our platform integrates biology, computation, and engineering to develop impactful antibody-based medicines. AbCellera is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women's health, immunology, and oncology. Biotechnology Research Specialties: Antibody Discovery, Cell Culture, Antibody Therapies, Protein Analysis, Microfluidic Single Cell Analysis, Single Cell Genomics, Monoclonal Antibody Discovery, Cell Enrichment, Cell Screening, Cell Recovery, Protein engineering, T cell engagers, Bispecifics